IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
Akums Drugs and Pharmaceuticals Limited is an Pharmaceutical based company, located in New Delhi, Akums Drugs and Pharmaceuticals Limited IPO size was 1856.74 Cr. and was issued at 679.00 per share. The share of Akums Drugs and Pharmaceuticals Limited were listed at 796.35 per share and are currently trading at 486.35 per share.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Manufactures critical high-voltage equipment for High Voltage Direct Current (HVDC) and Flexible AC Transmission Systems (FACTS) networks, enabling energy transition from renewable sources to power gr
Sangli
business of global digital and technology services with artificial intelligence.
Mumbai
Akums Drugs and Pharmaceuticals operates in Pharmaceutical and Pharmaceuticals. The Issue is listed on BSE,NSE in Aug, 2024. Akums Drugs and Pharmaceuticals IPO size was 1856.74 Cr. with Issue price of 679.00 .
Merchant Banker(s) of Akums Drugs and Pharmaceuticals IPO: Ambit Private Limited , Axis Bank Limited , Citigroup Global Markets India Private Limited , ICICI Securities Limited
Akums Drugs and Pharmaceuticals IPO subscription was 63.44 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Akums Drugs and Pharmaceuticals IPO listed at a listing price of 796.35 against the offer price of 679.00.
The current market price of Akums Drugs and Pharmaceuticals is 486.35.
Why Us?
